Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

12.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.8K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.5K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.5K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

134
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
134

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous infusion [<sup>11</sup>C]-(+)-PHNO PET for measuring dopamine D<sub>2/3</sub> receptor availability and amphetamine effects across the brain: Feasibility and test-retest reliability.

European journal of nuclear medicine and molecular imaging·2026
Same author

Comparable Neutralizing Antibody Responses Following JN.1 and KP.2-Based COVID-19 Vaccination Suggest Limited Added Value of Minor Strain Updates: A Multicentre Immunogenicity Study.

Influenza and other respiratory viruses·2026
Same author

Prostatic tissue distribution of gepotidacin in patients undergoing prostatectomy: an ex vivo microdialysis and pharmacokinetic modelling study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Efficacy of ceftazidime/avibactam against 10 clinical isolates of Pseudomonas aeruginosa in icodextrin-based peritoneal dialysis solution and patient-derived dialysate.

The Journal of antimicrobial chemotherapy·2026
Same author

Endovascular thrombectomy with or without intravenous thrombolysis in large-vessel ischemic stroke: an updated meta-analysis.

Scientific reports·2026
Same author

Impact of cardiopulmonary bypass on cefuroxime plasma and interstitial tissue concentrations in patients undergoing cardiac bypass surgery-a prospective controlled clinical trial.

The Journal of antimicrobial chemotherapy·2026

Related Experiment Video

Updated: Jun 7, 2025

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.7K

Insights into interspecies protein binding variability using clindamycin as an example.

Hifza Ahmed1, Michaela Böhmdorfer2, Walter Jäger2

  • 1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

The Journal of Antimicrobial Chemotherapy
|November 18, 2024
PubMed
Summary
This summary is machine-generated.

Interspecies differences in plasma protein binding (PPB) of clindamycin affect its antibacterial efficacy. Rat plasma showed lower binding and reduced bacterial killing compared to human and bovine plasma, impacting preclinical study relevance.

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.7K
The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
19:16

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis

Published on: March 17, 2010

20.6K

Related Experiment Videos

Last Updated: Jun 7, 2025

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.7K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.7K
The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
19:16

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis

Published on: March 17, 2010

20.6K

Area of Science:

  • Pharmacology
  • Microbiology
  • Translational Medicine

Background:

  • Preclinical drug development relies on animal models for predicting human efficacy via pharmacokinetic/pharmacodynamic (PK/PD) studies.
  • Plasma protein binding (PPB) and bacterial growth dynamics are critical factors in antimicrobial efficacy.
  • Clindamycin, a widely used antibiotic, was investigated in various plasma environments.

Purpose of the Study:

  • To compare the plasma protein binding of clindamycin across human, bovine, and rat plasma.
  • To evaluate the impact of different plasma concentrations on clindamycin's antibacterial activity against Staphylococcus aureus.
  • To assess the translational relevance of animal models in preclinical antimicrobial drug development.

Main Methods:

  • Plasma protein binding (PPB) of clindamycin was determined using ultrafiltration (UF) and equilibrium dialysis (ED) in human, bovine, and rat plasma.
  • Bacterial growth and time-kill assays were conducted in Mueller-Hinton broth (MHB) supplemented with varying percentages of plasma (20%–70%).
  • Antibiotic concentrations were tested across a range, including sub-MIC levels.

Main Results:

  • Clindamycin PPB showed good correlation between UF and ED methods.
  • Rat plasma exhibited significantly lower clindamycin binding compared to human and bovine plasma.
  • Staphylococcus aureus growth was inhibited in 70% plasma, with enhanced killing observed in human and bovine plasma at higher concentrations and longer incubation times.

Conclusions:

  • Interspecies variations in plasma protein binding are crucial for accurate preclinical study interpretation.
  • Differences in clindamycin binding and efficacy between rat and human/bovine plasma highlight potential limitations in using rat models for translational PK/PD studies.
  • Optimizing preclinical studies requires careful consideration of species-specific plasma protein binding characteristics.